<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04702165</url>
  </required_header>
  <id_info>
    <org_study_id>2020P002692</org_study_id>
    <nct_id>NCT04702165</nct_id>
  </id_info>
  <brief_title>Image - Navigated Resection of Lung Nodules</brief_title>
  <official_title>Image - Navigated Resection of Lung Nodules</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Navigation Sciences, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Navigation Sciences, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an open label study lung nodules that are either cancer or non-cancer and who are&#xD;
      eligible for surgical resection. Patients will undergo their surgery with the help of the&#xD;
      Lung Resection Marker Locator Kit which will assist the surgeon in both the location and&#xD;
      resection of the lung nodule under real-time guidance.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 3, 2021</start_date>
  <completion_date type="Anticipated">January 2023</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To compare the measurements from the J-bar fiducial to the first staple line obtained by the device in vivo to that performed in the frozen section room on the lung specimen obtained (which includes both the J bar and the staple line).</measure>
    <time_frame>1 day</time_frame>
    <description>device feasibility</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>whether coefficient is needed</measure>
    <time_frame>1 day</time_frame>
    <description>To determine whether a coefficient needs to be defined to harmonize the distance measured with the device to that found by pathologists</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time required for device placement</measure>
    <time_frame>1 day</time_frame>
    <description>3. To determine the length of time needed for the placement of the device and record measurements.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>demonstrate safe surgical remove of lung nodule</measure>
    <time_frame>30 day</time_frame>
    <description>no increased surgical morbidity from the operation</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Lung Diseases</condition>
  <arm_group>
    <arm_group_label>VATS resection with J-bar</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each patient with a lung nodule meeting criteria will undergo a lung resection which could be one of three approaches: iVATS with Dyna-CT, VATS, or open. Each approach will use a the experimental device the Lung Resection Marker Locator Kit</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>lung resection with Lung Resection Marker Locator Kit</intervention_name>
    <description>Nodules eligible for surgical resection using the Lung Resection Marker Locator Kit</description>
    <arm_group_label>VATS resection with J-bar</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Males or females aged 21 years or older as it is extremely rare for younger people to&#xD;
             be at risk for lung cancers.&#xD;
&#xD;
          2. Be deemed candidates for the lung resection surgery, which will be determined by their&#xD;
             treating Thoracic Surgeon (also a physician investigator)&#xD;
&#xD;
          3. Have lesions that are nodules/GGO or other abnormal opacity that can be accurately&#xD;
             measured in at least one dimension using conventional techniques&#xD;
&#xD;
          4. Seen at BWH Thoracic Surgery outpatient clinics or as inpatient (Note: Subjects will&#xD;
             be formally consented to the study at BWH only)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Female subjects pregnant or breastfeeding&#xD;
&#xD;
          2. Subjects with a pacemaker or equivalent devices (AICD) due to the use of&#xD;
             electromagnetic tracking generator.&#xD;
&#xD;
          3. Patients who are not scheduled for lung surgery&#xD;
&#xD;
             -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Scott J Swanson, MD</last_name>
    <phone>617-525-7532</phone>
    <email>sjswanson@bwh.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julianne Barlow, MS</last_name>
    <phone>617-525-8704</phone>
    <email>jbarlow1@bwh.harvard.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott Swanson, MD</last_name>
      <email>sjswanson@bwh.harvard.edu</email>
    </contact>
    <contact_backup>
      <last_name>Julianne Barlow, MS</last_name>
      <email>jbarlow1@bwh.harvard.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>December 23, 2020</study_first_submitted>
  <study_first_submitted_qc>January 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 8, 2021</study_first_posted>
  <last_update_submitted>August 30, 2021</last_update_submitted>
  <last_update_submitted_qc>August 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>lung nodule</keyword>
  <keyword>lung cancer</keyword>
  <keyword>lung mass</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

